2024
DOI: 10.3390/jcm13082196
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Cardiovascular Risk Categories and Achievement of Therapeutic Targets in European Patients with Type 2 Diabetes

Delia Reurean-Pintilei,
Claudia-Gabriela Potcovaru,
Teodor Salmen
et al.

Abstract: Background: Individuals diagnosed with type 2 diabetes mellitus (T2DM) are more prone to experiencing severe cardiovascular (CV) events, often occurring at a younger age, due to a complex interplay of risk factors. T2DM diagnosis inherently classifies patients as belonging to a higher CV risk group. In light of the increased susceptibility to severe CV outcomes, our study aims to assess the distribution of CV risk categories and the attainment of therapeutic targets among Romanian patients diagnosed with T2DM.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…One notable strength of our study is the cohort's well-controlled BP values and nearly optimal metabolic control. However, reports indicate that despite meeting glycemic control targets, most patients do not achieve a comprehensive treatment goal encompassing HbA1c, BP, and lipid levels, and there is an underutilization of newer antidiabetic medications with potential cardio-and reno-protective benefits [66][67][68][69]. Our study may constitute the baseline for a longitudinal follow-up of the same cohort.…”
Section: Strengths and Limitationsmentioning
confidence: 93%
“…One notable strength of our study is the cohort's well-controlled BP values and nearly optimal metabolic control. However, reports indicate that despite meeting glycemic control targets, most patients do not achieve a comprehensive treatment goal encompassing HbA1c, BP, and lipid levels, and there is an underutilization of newer antidiabetic medications with potential cardio-and reno-protective benefits [66][67][68][69]. Our study may constitute the baseline for a longitudinal follow-up of the same cohort.…”
Section: Strengths and Limitationsmentioning
confidence: 93%